 Although MDS is often under-diagnosed, leading the believed actual incidence rate to be estimated at 35,000 to 55,000 new cases annually.One in three people with MDS progress to acute myeloid leukemia.For lower risk patients, those who do not undergo a bone marrow transplant have an average survival rate of up to six years.